Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited 2096.HK Peers
See (2096.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2096.HK | HK$12.20 | -2.09% | 30.3B | 38.13 | HK$0.32 | +1.44% |
| 1801.HK | HK$65.05 | +3.09% | 107.3B | -929.29 | -HK$0.07 | N/A |
| 2269.HK | HK$24.70 | -1.00% | 100.5B | 29.06 | HK$0.85 | N/A |
| 1177.HK | HK$4.48 | +1.82% | 80.2B | 40.73 | HK$0.11 | +1.34% |
| 9926.HK | HK$80.70 | +7.60% | 72.3B | -124.15 | -HK$0.65 | N/A |
| 1530.HK | HK$19.70 | +3.90% | 46.5B | 21.41 | HK$0.92 | +1.27% |
| 3759.HK | HK$15.74 | +6.93% | 43.5B | 13.69 | HK$1.15 | +1.64% |
| 6821.HK | HK$73.10 | +1.60% | 34.9B | 23.81 | HK$3.07 | +2.48% |
| 1877.HK | HK$20.75 | +9.21% | 34.5B | -14.72 | -HK$1.41 | N/A |
| 9995.HK | HK$50.55 | +5.97% | 34.2B | -17.02 | -HK$2.97 | N/A |
Stock Comparison
2096.HK vs 1801.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1801.HK has a market cap of 107.3B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1801.HK trades at HK$65.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1801.HK's P/E ratio is -929.29. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1801.HK's ROE of -0.01%. Regarding short-term risk, 2096.HK is more volatile compared to 1801.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2269.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2269.HK has a market cap of 100.5B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2269.HK trades at HK$24.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2269.HK's P/E ratio is 29.06. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2269.HK's ROE of +0.06%. Regarding short-term risk, 2096.HK is more volatile compared to 2269.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1177.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1177.HK has a market cap of 80.2B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1177.HK trades at HK$4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1177.HK's P/E ratio is 40.73. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1177.HK's ROE of +0.11%. Regarding short-term risk, 2096.HK is more volatile compared to 1177.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 9926.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 9926.HK has a market cap of 72.3B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 9926.HK trades at HK$80.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 9926.HK's P/E ratio is -124.15. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 9926.HK's ROE of -0.09%. Regarding short-term risk, 2096.HK is more volatile compared to 9926.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1530.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1530.HK has a market cap of 46.5B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1530.HK trades at HK$19.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1530.HK's P/E ratio is 21.41. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1530.HK's ROE of +0.14%. Regarding short-term risk, 2096.HK is more volatile compared to 1530.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 3759.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 3759.HK has a market cap of 43.5B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 3759.HK trades at HK$15.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 3759.HK's P/E ratio is 13.69. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 3759.HK's ROE of +0.14%. Regarding short-term risk, 2096.HK is more volatile compared to 3759.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 6821.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 6821.HK has a market cap of 34.9B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 6821.HK trades at HK$73.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 6821.HK's P/E ratio is 23.81. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 6821.HK's ROE of +0.06%. Regarding short-term risk, 2096.HK is more volatile compared to 6821.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1877.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1877.HK has a market cap of 34.5B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1877.HK trades at HK$20.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1877.HK's P/E ratio is -14.72. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1877.HK's ROE of -0.20%. Regarding short-term risk, 2096.HK is less volatile compared to 1877.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 9995.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 9995.HK has a market cap of 34.2B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 9995.HK trades at HK$50.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 9995.HK's P/E ratio is -17.02. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 9995.HK's ROE of -0.58%. Regarding short-term risk, 2096.HK is more volatile compared to 9995.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1548.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1548.HK has a market cap of 28.3B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1548.HK trades at HK$13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1548.HK's P/E ratio is -20.62. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1548.HK's ROE of -0.06%. Regarding short-term risk, 2096.HK is more volatile compared to 1548.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 9688.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 9688.HK has a market cap of 26.5B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 9688.HK trades at HK$24.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 9688.HK's P/E ratio is -12.32. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 9688.HK's ROE of -0.33%. Regarding short-term risk, 2096.HK is more volatile compared to 9688.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2696.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2696.HK has a market cap of 25.2B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2696.HK trades at HK$46.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2696.HK's P/E ratio is 28.08. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2696.HK's ROE of +0.29%. Regarding short-term risk, 2096.HK is more volatile compared to 2696.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 6855.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 6855.HK has a market cap of 18.5B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 6855.HK trades at HK$53.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 6855.HK's P/E ratio is -36.58. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 6855.HK's ROE of -0.79%. Regarding short-term risk, 2096.HK is less volatile compared to 6855.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 9969.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 9969.HK has a market cap of 16.5B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 9969.HK trades at HK$11.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 9969.HK's P/E ratio is -39.43. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 9969.HK's ROE of -0.06%. Regarding short-term risk, 2096.HK is more volatile compared to 9969.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1952.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1952.HK has a market cap of 14.8B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1952.HK trades at HK$45.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1952.HK's P/E ratio is -12.90. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1952.HK's ROE of -0.24%. Regarding short-term risk, 2096.HK is more volatile compared to 1952.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 6826.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 6826.HK has a market cap of 12.2B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 6826.HK trades at HK$26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 6826.HK's P/E ratio is 13.67. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 6826.HK's ROE of +0.07%. Regarding short-term risk, 2096.HK is more volatile compared to 6826.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2162.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2162.HK has a market cap of 12.1B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2162.HK trades at HK$44.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2162.HK's P/E ratio is -20.58. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2162.HK's ROE of -0.20%. Regarding short-term risk, 2096.HK is more volatile compared to 2162.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2171.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2171.HK has a market cap of 12.1B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2171.HK trades at HK$21.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2171.HK's P/E ratio is -13.56. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2171.HK's ROE of +0.00%. Regarding short-term risk, 2096.HK is less volatile compared to 2171.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 9966.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 9966.HK has a market cap of 8.1B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 9966.HK trades at HK$8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 9966.HK's P/E ratio is 46.89. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 9966.HK's ROE of +0.10%. Regarding short-term risk, 2096.HK is less volatile compared to 9966.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 0775.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 0775.HK has a market cap of 8.1B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 0775.HK trades at HK$0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 0775.HK's P/E ratio is -84.00. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 0775.HK's ROE of -0.03%. Regarding short-term risk, 2096.HK is more volatile compared to 0775.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2157.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2157.HK has a market cap of 7.9B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2157.HK trades at HK$4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2157.HK's P/E ratio is -18.27. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2157.HK's ROE of -0.51%. Regarding short-term risk, 2096.HK is more volatile compared to 2157.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1672.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1672.HK has a market cap of 7.7B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1672.HK trades at HK$8.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1672.HK's P/E ratio is -25.09. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1672.HK's ROE of -0.15%. Regarding short-term risk, 2096.HK is more volatile compared to 1672.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2142.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2142.HK has a market cap of 7.4B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2142.HK trades at HK$9.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2142.HK's P/E ratio is 303.00. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2142.HK's ROE of +0.02%. Regarding short-term risk, 2096.HK is more volatile compared to 2142.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2315.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2315.HK has a market cap of 7.2B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2315.HK trades at HK$17.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2315.HK's P/E ratio is 199.78. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2315.HK's ROE of -0.19%. Regarding short-term risk, 2096.HK is less volatile compared to 2315.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2256.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2256.HK has a market cap of 6.5B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2256.HK trades at HK$9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2256.HK's P/E ratio is 239.75. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2256.HK's ROE of +0.01%. Regarding short-term risk, 2096.HK is more volatile compared to 2256.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1477.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1477.HK has a market cap of 6.4B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1477.HK trades at HK$7.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1477.HK's P/E ratio is -18.62. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1477.HK's ROE of -0.08%. Regarding short-term risk, 2096.HK is more volatile compared to 1477.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1541.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1541.HK has a market cap of 5.6B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1541.HK trades at HK$14.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1541.HK's P/E ratio is -15.52. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1541.HK's ROE of -0.49%. Regarding short-term risk, 2096.HK is less volatile compared to 1541.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2616.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2616.HK has a market cap of 5.5B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2616.HK trades at HK$4.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2616.HK's P/E ratio is -50.75. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2616.HK's ROE of -0.22%. Regarding short-term risk, 2096.HK is less volatile compared to 2616.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 6660.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 6660.HK has a market cap of 4.8B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 6660.HK trades at HK$3.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 6660.HK's P/E ratio is -15.72. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 6660.HK's ROE of -0.08%. Regarding short-term risk, 2096.HK is less volatile compared to 6660.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2179.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2179.HK has a market cap of 4.2B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2179.HK trades at HK$8.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2179.HK's P/E ratio is -6.74. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2179.HK's ROE of -0.82%. Regarding short-term risk, 2096.HK is more volatile compared to 2179.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1167.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1167.HK has a market cap of 4.1B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1167.HK trades at HK$5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1167.HK's P/E ratio is -23.86. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1167.HK's ROE of -0.17%. Regarding short-term risk, 2096.HK is more volatile compared to 1167.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1873.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1873.HK has a market cap of 3.7B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1873.HK trades at HK$1.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1873.HK's P/E ratio is 25.43. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1873.HK's ROE of +0.04%. Regarding short-term risk, 2096.HK is more volatile compared to 1873.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2487.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2487.HK has a market cap of 3B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2487.HK trades at HK$9.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2487.HK's P/E ratio is -6.34. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2487.HK's ROE of -0.40%. Regarding short-term risk, 2096.HK is less volatile compared to 2487.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2509.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2509.HK has a market cap of 2.7B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2509.HK trades at HK$11.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2509.HK's P/E ratio is -7.20. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2509.HK's ROE of -1.12%. Regarding short-term risk, 2096.HK is less volatile compared to 2509.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 6996.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 6996.HK has a market cap of 2.6B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 6996.HK trades at HK$4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 6996.HK's P/E ratio is -7.44. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 6996.HK's ROE of -0.35%. Regarding short-term risk, 2096.HK is more volatile compared to 6996.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 3681.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 3681.HK has a market cap of 2.4B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 3681.HK trades at HK$2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 3681.HK's P/E ratio is -11.11. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 3681.HK's ROE of -0.79%. Regarding short-term risk, 2096.HK is less volatile compared to 3681.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1521.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1521.HK has a market cap of 2.3B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1521.HK trades at HK$1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1521.HK's P/E ratio is 56.00. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1521.HK's ROE of +0.00%. Regarding short-term risk, 2096.HK is more volatile compared to 1521.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2181.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2181.HK has a market cap of 2.1B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2181.HK trades at HK$0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2181.HK's P/E ratio is -16.67. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2181.HK's ROE of -1.25%. Regarding short-term risk, 2096.HK is less volatile compared to 2181.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 6622.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 6622.HK has a market cap of 1.7B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 6622.HK trades at HK$3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 6622.HK's P/E ratio is -6.47. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 6622.HK's ROE of -0.12%. Regarding short-term risk, 2096.HK is more volatile compared to 6622.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 6978.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 6978.HK has a market cap of 1.6B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 6978.HK trades at HK$3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 6978.HK's P/E ratio is -7.90. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 6978.HK's ROE of -0.01%. Regarding short-term risk, 2096.HK is more volatile compared to 6978.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1875.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1875.HK has a market cap of 1.5B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1875.HK trades at HK$1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1875.HK's P/E ratio is 37.20. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1875.HK's ROE of +0.05%. Regarding short-term risk, 2096.HK is more volatile compared to 1875.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2137.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2137.HK has a market cap of 1.4B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2137.HK trades at HK$1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2137.HK's P/E ratio is -2.45. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2137.HK's ROE of -0.18%. Regarding short-term risk, 2096.HK is more volatile compared to 2137.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 6998.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 6998.HK has a market cap of 1.4B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 6998.HK trades at HK$2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 6998.HK's P/E ratio is -23.55. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 6998.HK's ROE of -0.05%. Regarding short-term risk, 2096.HK is more volatile compared to 6998.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1244.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1244.HK has a market cap of 1B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1244.HK trades at HK$4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1244.HK's P/E ratio is -5.13. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1244.HK's ROE of -0.22%. Regarding short-term risk, 2096.HK is more volatile compared to 1244.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2511.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2511.HK has a market cap of 1B. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2511.HK trades at HK$1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2511.HK's P/E ratio is -2.14. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2511.HK's ROE of -0.00%. Regarding short-term risk, 2096.HK is less volatile compared to 2511.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2496.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2496.HK has a market cap of 820M. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2496.HK trades at HK$4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2496.HK's P/E ratio is -7.83. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2496.HK's ROE of -3.00%. Regarding short-term risk, 2096.HK is more volatile compared to 2496.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2126.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2126.HK has a market cap of 770.2M. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2126.HK trades at HK$1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2126.HK's P/E ratio is -1.23. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2126.HK's ROE of -0.45%. Regarding short-term risk, 2096.HK is more volatile compared to 2126.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 6628.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 6628.HK has a market cap of 649.4M. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 6628.HK trades at HK$1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 6628.HK's P/E ratio is -1.95. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 6628.HK's ROE of -0.35%. Regarding short-term risk, 2096.HK is less volatile compared to 6628.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2185.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2185.HK has a market cap of 634M. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2185.HK trades at HK$2.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2185.HK's P/E ratio is -6.90. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2185.HK's ROE of -0.13%. Regarding short-term risk, 2096.HK is less volatile compared to 2185.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 9939.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 9939.HK has a market cap of 581.8M. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 9939.HK trades at HK$1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 9939.HK's P/E ratio is -3.44. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 9939.HK's ROE of +0.00%. Regarding short-term risk, 2096.HK is more volatile compared to 9939.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 0690.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 0690.HK has a market cap of 512.6M. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 0690.HK trades at HK$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 0690.HK's P/E ratio is 8.20. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 0690.HK's ROE of +0.26%. Regarding short-term risk, 2096.HK is more volatile compared to 0690.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2257.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2257.HK has a market cap of 400.7M. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2257.HK trades at HK$3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2257.HK's P/E ratio is -0.74. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2257.HK's ROE of +71.56%. Regarding short-term risk, 2096.HK is more volatile compared to 2257.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 2197.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 2197.HK has a market cap of 300.9M. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 2197.HK trades at HK$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 2197.HK's P/E ratio is -0.30. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 2197.HK's ROE of +0.73%. Regarding short-term risk, 2096.HK is less volatile compared to 2197.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 8158.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 8158.HK has a market cap of 120.2M. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 8158.HK trades at HK$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 8158.HK's P/E ratio is 6.58. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 8158.HK's ROE of +0.71%. Regarding short-term risk, 2096.HK is less volatile compared to 8158.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.
2096.HK vs 1228.HK Comparison
2096.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2096.HK stands at 30.3B. In comparison, 1228.HK has a market cap of 68M. Regarding current trading prices, 2096.HK is priced at HK$12.20, while 1228.HK trades at HK$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2096.HK currently has a P/E ratio of 38.13, whereas 1228.HK's P/E ratio is -0.14. In terms of profitability, 2096.HK's ROE is +0.10%, compared to 1228.HK's ROE of +1.17%. Regarding short-term risk, 2096.HK is less volatile compared to 1228.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2096.HK.